Skip to main content
Fig. 1 | Stem Cell Research & Therapy

Fig. 1

From: Exosomal microRNA-144 from bone marrow-derived mesenchymal stem cells inhibits the progression of non-small cell lung cancer by targeting CCNE1 and CCNE2

Fig. 1

High expression of CCNE1 and CCNE2 in NSCLC tissues and cells. a Comparisons of differently expressed genes in the expression profile of NSCLCs GSE74706 and GSE33532. b KEGG pathway enrichment of the DEGs in NSCLC analyzed by DAVID software. c, d Expression of CCNE1 and CCNE2 in expression profile of NSCLC GSE74706 and GSE33532. e Correlation analysis of expression of CCNE1 and CCNE2. f The expression of CCNE1 and CCNE2 in NSCLC tissues and adjacent normal tissues determined by RT-qPCR. g The expression of CCNE1 and CCNE2 protein in NSCLC tissues and adjacent normal tissues tested by western blot analysis. h Expression of CCNE1 and CCNE2 in NSCLC tissues detected by IHC (× 400). *p < 0.05 vs. the adjacent normal tissues. i The expression of CCNE1 and CCNE2 in different NSCLC cell lines measured by RT-qPCR. j The expression of CCNE1 and CCNE2 in different NSCLC cell lines assessed by western blot analysis. *p < 0.05 vs. the HBE cell line. The above measurement data were expressed as mean ± standard deviation. Comparisons between tumor tissues and adjacent normal tissues were analyzed by paired t test. Comparisons between two groups were analyzed by unpaired t test. The experiment was repeated in triplicate

Back to article page